Compare GLP vs GMP in pharmaceutical laboratories, including their scope, records, quality oversight, regulations, and practical examples.
When comparing GLP vs GMP, the key difference is what each system controls. Good Laboratory Practice (GLP) supports the reliability and integrity of certain nonclinical study data. Good Manufacturing Practice (GMP) controls how medicines are manufactured, tested, packed, and handled so they meet applicable quality requirements.
Both matter in pharmaceutical development, but they are not interchangeable. A laboratory may perform GLP studies, GMP quality-control testing, or both, depending on the activity and regulatory purpose.
What does GLP mean in pharmaceutical research?
GLP is a quality system for the organization and conduct of nonclinical laboratory studies. It covers how studies are planned, performed, monitored, recorded, reported, and retained. In the United States, FDA requirements for relevant nonclinical studies are set out in 21 CFR Part 58. OECD GLP principles provide an internationally used framework for the quality and integrity of nonclinical safety data.
In a pharmaceutical development program, a GLP study might evaluate a drug candidate’s toxicity before human testing. The study follows an approved protocol, assigns a study director, records raw data, and undergoes quality assurance inspections. The final report and supporting records are retained so the study can be reviewed and reconstructed.
GLP does not apply to every experiment performed in a research laboratory. Applicability depends on the study’s purpose, the product, the regulatory pathway, and the rules in the relevant jurisdiction.
What does GMP mean in pharmaceutical production?
GMP—often called cGMP in the United States—concerns the systems and controls used in drug manufacturing and related operations. FDA’s regulations in 21 CFR Parts 210 and 211 cover current GMP for drugs and finished pharmaceuticals. In the European Union, EudraLex Volume 4 provides GMP guidance for human and veterinary medicinal products.
For example, a tablet manufacturer uses approved procedures and batch records to document dispensing, blending, compression, packaging, and testing. A pharmaceutical quality-control unit reviews relevant records and has authority to approve or reject materials and products under FDA requirements.
GLP vs GMP
| Area | GLP | GMP |
|---|---|---|
| Main purpose | Support reliable nonclinical study data | Control manufacturing and product quality |
| Typical setting | Toxicology or other regulated nonclinical study facility | Manufacturing site and pharmaceutical QC laboratory |
| Main focus | Study protocol, conduct, raw data, report, and archives | Materials, procedures, processes, batch records, testing, and product disposition |
| Quality oversight | FDA GLP requires a quality assurance unit independent of the personnel conducting each study | FDA GMP requires a quality control unit with defined responsibilities and authority; this is not the same structure as the GLP quality assurance unit |
| Typical output | Study report and supporting records | Documented batch and test results supporting quality decisions |
Under FDA GLP, the quality assurance unit must be separate from and independent of the personnel directing or conducting the study. GMP regulations instead define responsibilities for the quality control unit, including reviewing records and approving or rejecting specified materials and products.
Practical pharmaceutical examples
Example 1: Nonclinical safety study. A sponsor commissions a toxicity study of a new drug candidate. If the study falls within applicable GLP requirements, the facility follows the study protocol, records observations and raw data, and conducts independent quality assurance inspections.
Example 2: Finished-batch testing. A QC analyst tests an amoxicillin tablet batch against approved specifications before release. The test is part of the GMP quality system: the method, sample, results, instrument records, and batch documentation must be controlled and reviewed. FDA regulations address laboratory controls and testing before distribution.
The fact that both examples involve laboratory work does not make both GLP activities. The deciding factor is the purpose of the work: generating regulated nonclinical study data or controlling a manufactured product.
Where GLP and GMP overlap
The systems can apply to different activities within the same company or facility. GLP study results may inform decisions about a drug candidate, while GMP controls the manufacture and testing of drug product. One system does not substitute for the other: a GLP-compliant study does not demonstrate that a production batch meets GMP, and GMP batch records do not establish that a nonclinical study complied with GLP.
Human-subject clinical trials are outside OECD GLP; applicable Good Clinical Practice requirements govern the clinical study. Rules for manufacturing investigational medicinal products depend on the jurisdiction and product.
Key takeaways
- GLP protects the quality and integrity of applicable nonclinical study data.
- GMP controls pharmaceutical manufacturing and product-quality activities.
- Routine batch-release testing in a pharmaceutical QC lab is generally part of the GMP system.
- GLP and GMP may both be relevant at one organization, but they apply to different activities.
- Confirm the applicable requirements for the product, study, and jurisdiction.
Frequently asked questions
1. What is the main difference between GLP and GMP?
GLP supports reliable nonclinical study data; GMP controls manufacturing and product quality.
2. Does GLP apply to routine pharmaceutical QC testing?
Routine testing of materials or finished batches is generally managed under applicable GMP requirements. GLP applies when testing is part of a regulated nonclinical study.
3. Does GLP compliance mean a site is GMP compliant?
No. GLP and GMP cover different activities and require separate assessments against the applicable rules.
4. Is GLP required for every preclinical experiment?
No. Whether GLP applies depends on the study’s regulatory purpose, product, and jurisdiction.
5. Which FDA regulation covers GLP?
FDA’s requirements for applicable nonclinical laboratory studies are in 21 CFR Part 58.
6. Which FDA regulations cover pharmaceutical GMP?
FDA’s general drug cGMP rules include 21 CFR Parts 210 and 211.
7. Is a GLP quality assurance unit independent?
Under FDA GLP, the quality assurance unit must be separate from and independent of personnel conducting the study.
8. Is GMP quality oversight the same as GLP quality assurance?
No. FDA GMP defines a quality control unit with specific authority and responsibilities; GLP specifies an independent quality assurance unit for studies.
9. Are clinical trials covered by GLP?
Human-subject studies are outside OECD GLP. Clinical studies follow applicable Good Clinical Practice requirements.
10. Can one company need both GLP and GMP?
Yes. A company may conduct GLP nonclinical studies and separately manufacture or test products under GMP controls.